Allogeneic hematopoietic SCT (HSCT) is an established treatment for some children with life-
threatening hematological disease, immune deficiencies and inborn errors of metabolism …

Donor lymphocyte infusion (DLI) using unstimulated leukapheresis is one of the most
effective treatment strategies for patients with hematological malignancies; its graft-versus …

Purpose To evaluate the role of donor lymphocyte infusion (DLI) in the treatment of relapsed
acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation …

Purpose To improve the effect of allogeneic stem-cell transplantation by sequential use of
intensive chemotherapy, reduced-intensity conditioning (RIC), and prophylactic donor …

Adjuvant transfusion of donor lymphocytes (aDLT) may reduce the risk of relapse after
allogeneic stem cell transplantation in high-risk AML. We performed a retrospective analysis …

Sixteen patients with adult T-cell leukemia/lymphoma (ATL) who were all over 50 years of
age underwent allogeneic stem cell transplantation with reduced-conditioning intensity …

Relapsed acute leukemia after allogeneic transplantation has a poor prognosis and most
reports have focused on the role of second transplantations in relapsed patients. We report …

The role of repopulating lymphocytes after allogeneic stem cell transplantation (SCT)
includes the prevention of serious infections and attacking residual tumour cells in the early …

Little data are available on the relative merits of chimerism and minimal residual disease
(MRD) monitoring for relapse prediction after allogeneic hematopoietic stem cell …

The success of hematopoietic stem cell transplantation (HSCT) with reduced-intensity
conditioning (RIC) is limited by a high rate of disease relapse. Early risk assessment could …